205 related articles for article (PubMed ID: 17000074)
41. Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey.
Bombard Y; Veenstra G; Friedman JM; Creighton S; Currie L; Paulsen JS; Bottorff JL; Hayden MR;
BMJ; 2009 Jun; 338():b2175. PubMed ID: 19509425
[TBL] [Abstract][Full Text] [Related]
42. Psychological costs and benefits of predictive testing for Huntington's disease.
Codori AM; Brandt J
Am J Med Genet; 1994 Sep; 54(3):174-84. PubMed ID: 7810575
[TBL] [Abstract][Full Text] [Related]
43. Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington's disease.
Schwartz RR
J Neurosci Nurs; 2010 Jun; 42(3):157-68. PubMed ID: 20550076
[TBL] [Abstract][Full Text] [Related]
44. The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.
Kayson E; Eberly S; Anderson KE; Marder K; Shoulson I; Oakes D; Young AB; Biglan K; Hersch S;
J Huntingtons Dis; 2019; 8(4):435-441. PubMed ID: 31381523
[TBL] [Abstract][Full Text] [Related]
45. Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cassiman JJ; Cloostermans T; Demyttenaere K; Dom R; Fryns JP; Van den Berghe H
J Med Genet; 1996 Sep; 33(9):737-43. PubMed ID: 8880572
[TBL] [Abstract][Full Text] [Related]
46. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J
J Med Genet; 1998 Sep; 35(9):745-54. PubMed ID: 9733033
[TBL] [Abstract][Full Text] [Related]
47. What do we tell the children? Contrasting the disclosure choices of two HD families regarding risk status and predictive genetic testing.
Holt K
J Genet Couns; 2006 Aug; 15(4):253-65. PubMed ID: 16850280
[TBL] [Abstract][Full Text] [Related]
48. Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent.
Bonnard A; Herson A; Gargiulo M; Durr A
Eur J Hum Genet; 2019 Jan; 27(1):22-27. PubMed ID: 30206353
[TBL] [Abstract][Full Text] [Related]
49. Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
Tibben A; Timman R; Bannink EC; Duivenvoorden HJ
Health Psychol; 1997 Jan; 16(1):20-35. PubMed ID: 9028813
[TBL] [Abstract][Full Text] [Related]
50. Uptake of presymptomatic predictive testing for Huntington's disease.
Craufurd D; Dodge A; Kerzin-Storrar L; Harris R
Lancet; 1989 Sep; 2(8663):603-5. PubMed ID: 2570293
[TBL] [Abstract][Full Text] [Related]
51. Psychosocial impact of predictive testing for Huntington disease on support persons.
Williams JK; Schutte DL; Holkup PA; Evers C; Muilenburg A
Am J Med Genet; 2000 Jun; 96(3):353-9. PubMed ID: 10898914
[TBL] [Abstract][Full Text] [Related]
52. Do Attachment Style and Emotion Regulation Strategies Indicate Distress in Predictive Testing?
van der Meer LB; van Duijn E; Giltay EJ; Tibben A
J Genet Couns; 2015 Oct; 24(5):862-71. PubMed ID: 25641254
[TBL] [Abstract][Full Text] [Related]
53. Psychological consequences of presymptomatic testing for Huntington's disease.
Mlynik-Szmid A
Lancet; 1997 Mar; 349(9054):808. PubMed ID: 9074603
[No Abstract] [Full Text] [Related]
54. Genetic discrimination in Huntington's disease.
Tibben A
BMJ; 2009 Jun; 338():b1281. PubMed ID: 19509423
[No Abstract] [Full Text] [Related]
55. Predictive testing for Huntington's disease: relationship with partners after testing.
Decruyenaere M; Evers-Kiebooms G; Cloostermans T; Boogaerts A; Demyttenaere K; Dom R; Fryns JP
Clin Genet; 2004 Jan; 65(1):24-31. PubMed ID: 15032971
[TBL] [Abstract][Full Text] [Related]
56. Genetic Counselling for Predictive Testing in Huntington's Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making.
Arning L; Witt CN; Epplen JT; Stemmler S
J Huntingtons Dis; 2015; 4(1):87-98. PubMed ID: 26333260
[TBL] [Abstract][Full Text] [Related]
57. Attachment in families with Huntington's disease. A paradigm in clinical genetics.
Van der Meer L; Timman R; Trijsburg W; Duisterhof M; Erdman R; Van Elderen T; Tibben A
Patient Educ Couns; 2006 Oct; 63(1-2):246-54. PubMed ID: 16427763
[TBL] [Abstract][Full Text] [Related]
58. A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.
Wadrup F; Holden S; MacLeod R; Miedzybrodzka Z; Németh AH; Owens S; Pasalodos S; Quarrell O; Clarke AJ;
Eur J Hum Genet; 2019 Aug; 27(8):1215-1224. PubMed ID: 30890781
[TBL] [Abstract][Full Text] [Related]
59. Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease.
Jankovic J; Beach J; Ashizawa T
J Med Genet; 1995 Jul; 32(7):516-8. PubMed ID: 7562962
[TBL] [Abstract][Full Text] [Related]
60. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.
Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Philippe K; Demyttenaere K; Dom R; Vandenberghe W; Fryns JP
Eur J Hum Genet; 2007 Apr; 15(4):453-62. PubMed ID: 17245406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
